MedTrace Logo

Vit D to Treat Asthma in Children: a Randomized, Double-blind, Placebo-controlled Trial

NCT01284907 · Status: WITHDRAWN · Phase: NA · Type: INTERVENTIONAL

Last updated 2014-12-17

No results posted yet for this study

Summary

The purpose of this study is to determine whether vitamin D supplements can improve asthma control in children with moderate to severe asthma

Conditions

Interventions

DIETARY_SUPPLEMENT

Vitamin D3 (Cholecalciferol)

Vit D3 ( Cholecalciferol) 1200 IU oral daily for 6 months

DIETARY_SUPPLEMENT

Placebo Drops

Sponsors & Collaborators

  • Roma Paediatrics

    collaborator UNKNOWN

  • United Arab Emirates University

    lead OTHER

Principal Investigators

  • Mariam Elremeli, MD · Roma Paediatrics

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
6 Years
Max Age
12 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2013-03-31
Primary Completion
2013-09-30
Completion
2013-12-31

Countries

  • United Arab Emirates

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01284907 on ClinicalTrials.gov